151 related articles for article (PubMed ID: 36433714)
1. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
[TBL] [Abstract][Full Text] [Related]
2. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
4. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer.
Li Q; Xiao Q; Yang M; Chai Q; Huang Y; Wu PY; Niu Q; Gu Y
Eur J Radiol; 2021 Jun; 139():109697. PubMed ID: 33857828
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
7. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Luo HB; Du MY; Liu YY; Wang M; Qing HM; Wen ZP; Xu GH; Zhou P; Ren J
Acad Radiol; 2020 Mar; 27(3):e35-e44. PubMed ID: 31151899
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis from ultrafast dynamic contrast-enhanced breast MRI using population-based versus individual arterial input functions, and comparison with semi-quantitative analysis.
Xie T; Zhao Q; Fu C; Grimm R; Dominik Nickel M; Hu X; Yue L; Peng W; Gu Y
Eur J Radiol; 2024 Jul; 176():111501. PubMed ID: 38788607
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Multiparametric MRI as an Imaging Biomarker for the Prediction of Breast Cancer Receptor Status and Molecular Subtypes.
Yang Z; Chen X; Zhang T; Cheng F; Liao Y; Chen X; Dai Z; Fan W
Front Oncol; 2021; 11():628824. PubMed ID: 34604024
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
13. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
14. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
15. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
[TBL] [Abstract][Full Text] [Related]
16. Preliminary MRI Study of Extracellular Volume Fraction for Identification of Lymphovascular Space Invasion of Cervical Cancer.
Wang W; Fan X; Yang J; Wang X; Gu Y; Chen M; Jiang Y; Liu L; Zhang M
J Magn Reson Imaging; 2023 Feb; 57(2):587-597. PubMed ID: 36094153
[TBL] [Abstract][Full Text] [Related]
17. [Association of parameters in dynamic contrast-enhanced MRI using reference region model with prognostic factors and molecular subtypes of breast cancer].
Li A; Pan Y; Chen B; Xia J; Gan F; Jin Y; Zheng J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):505-510. PubMed ID: 29488717
[TBL] [Abstract][Full Text] [Related]
18. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
[TBL] [Abstract][Full Text] [Related]
19. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
Du S; Gao S; Zhang L; Yang X; Qi X; Li S
Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
